1.

Record Nr.

UNINA9910813400103321

Autore

Franks Felix

Titolo

Freeze-drying of pharmaceuticals and biopharmaceuticals : [principles and practice] / / Felix Franks ; in association with Tony Auffret

Pubbl/distr/stampa

Cambridge : , : RSC Publishing, , 2007

©2007

ISBN

1-84755-770-8

Descrizione fisica

1 online resource (xii, 206 pages) : illustrations

Altri autori (Persone)

AuffretTony

Disciplina

615.18

Soggetti

Frozen drugs

Freeze-drying

Biopharmaceutics

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references (p. 190-200) and index.

Sommario/riassunto

Freeze-drying, in the past popular in the food industry, has more recently been adopted by the pharmaceutical industry as a standard method for the production of stable solid preparations. Freeze-drying of Pharmaceuticals and Biopharmaceuticals is the first book to specifically describe this process, as related to the pharmaceutical industry. The emphasis of this book is on the properties of the materials processed, how effective formulations are arrived at, and how they are stored and marketed. Beginning with a historical overview of the process, Freeze-drying of Pharmaceuticals and Biopharmaceuticals briefly describes the processes and equipment involved, including: the physics, chemistry and biochemistry associated with freezing, aspects of formulation development, primary and secondary drying; the economics and engineering of scaling up; and, most importantly, attributes of the dried product. It also discusses in detail the science behind freeze-drying, such as the properties of crystalline and amorphous solids. The book concludes with selected case studies and discusses the future of freeze-drying, advances in alternative drying methods, and concludes with an extensive bibliography. This book, written by a leading expert in the field, is aimed primarily at product



and process developers in the biopharmaceutical industry and academia.